News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,395 Results
Type
Article (23176)
Company Profile (33)
Press Release (362184)
Multimedia
Podcasts (122)
Webinars (14)
Section
Business (120364)
Career Advice (1420)
Deals (17710)
Drug Delivery (70)
Drug Development (43022)
Employer Resources (95)
FDA (8948)
Job Trends (8480)
News (192763)
Policy (17337)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1474)
Academic (1)
Accelerated approval (21)
Adcomms (15)
Allergies (104)
Alliances (33418)
ALS (126)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (239)
Approvals (9250)
Artificial intelligence (409)
Autoimmune disease (156)
Automation (36)
Bankruptcy (161)
Best Places to Work (7058)
BIOSECURE Act (6)
Biosimilars (129)
Biotechnology (29)
Bladder cancer (124)
Brain cancer (34)
Breast cancer (449)
Cancer (3528)
Cardiovascular disease (302)
Career advice (1229)
Career pathing (33)
CAR-T (159)
CDC (27)
Cell therapy (505)
Cervical cancer (27)
Clinical research (37740)
Collaboration (1447)
Company closure (2)
Compensation (381)
Complete response letters (31)
COVID-19 (1509)
CRISPR (66)
C-suite (536)
Cystic fibrosis (84)
Data (4951)
Decentralized trials (3)
Denatured (42)
Depression (93)
Dermatology (41)
Diabetes (377)
Diagnostics (3695)
Digital health (32)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (198)
Drug pricing (103)
Drug shortages (20)
Duchenne muscular dystrophy (173)
Earnings (59238)
Editorial (46)
Employer branding (12)
Employer resources (83)
Events (59012)
Executive appointments (587)
FDA (11222)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (933)
Gene editing (136)
Generative AI (44)
Gene therapy (456)
GLP-1 (623)
Government (2386)
Grass and pollen (6)
Guidances (333)
Healthcare (10314)
HIV (55)
Huntington's disease (35)
IgA nephropathy (63)
Immunology and inflammation (156)
Immuno-oncology (57)
Indications (125)
Infectious disease (1683)
Inflammatory bowel disease (134)
Inflation Reduction Act (12)
Influenza (72)
Intellectual property (165)
Interviews (265)
IPO (8494)
IRA (30)
Job creations (1733)
Job search strategy (992)
JPM (44)
Kidney cancer (10)
Labor market (54)
Layoffs (256)
Leadership (32)
Legal (4449)
Liver cancer (53)
Longevity (15)
Lung cancer (480)
Lymphoma (292)
Machine learning (30)
Management (32)
Manufacturing (570)
MASH (130)
Medical device (7072)
Medtech (7118)
Mergers & acquisitions (9973)
Metabolic disorders (931)
mRNA (105)
Multiple sclerosis (121)
NASH (9)
Neurodegenerative disease (233)
Neuropsychiatric disorders (54)
Neuroscience (1896)
NextGen: Class of 2026 (3444)
Non-profit (2718)
Now hiring (11)
Obesity (408)
Opinion (206)
Ovarian cancer (104)
Pain (144)
Pancreatic cancer (157)
Parkinson's disease (208)
Partnered (21)
Patents (324)
Patient recruitment (322)
Peanut (31)
People (28844)
Pharmaceutical (10)
Pharmacy benefit managers (18)
Phase 1 (11229)
Phase 2 (16108)
Phase 3 (13501)
Pipeline (5336)
Policy (168)
Postmarket research (1657)
Preclinical (4906)
Press Release (31)
Prostate cancer (232)
Psychedelics (28)
Radiopharmaceuticals (182)
Rare diseases (641)
Real estate (2583)
Recruiting (37)
Regulatory (13455)
Reports (23)
Research institute (1373)
Resumes & cover letters (217)
Rett syndrome (21)
RNA editing (11)
RSV (50)
Schizophrenia (106)
Series A (172)
Series B (102)
Service/supplier (3)
Sickle cell disease (74)
Special edition (14)
Spinal muscular atrophy (82)
Sponsored (29)
Startups (1544)
State (1)
Stomach cancer (11)
Supply chain (59)
Tariffs (38)
The Weekly (79)
Vaccines (625)
Venture capital (52)
Weight loss (247)
Women's health (61)
Worklife (15)
Date
Last 7 days (416)
Last 30 days (1726)
Last 365 days (19283)
2026 (5231)
2025 (19292)
2024 (20545)
2023 (22664)
2022 (28573)
2021 (30445)
2020 (29600)
2019 (25405)
2018 (18799)
2017 (17789)
2016 (17334)
2015 (19773)
2014 (16534)
2013 (14455)
2012 (14257)
2011 (13609)
2010 (12864)
Location
Africa (546)
Alabama (63)
Alaska (4)
Arizona (146)
Arkansas (7)
Asia (22580)
Australia (3725)
California (7379)
Canada (2162)
China (750)
Colorado (345)
Connecticut (369)
Delaware (229)
Europe (52864)
Florida (1210)
Georgia (264)
Hawaii (1)
Idaho (25)
Illinois (561)
India (59)
Indiana (401)
Iowa (10)
Japan (338)
Kansas (76)
Kentucky (18)
Louisiana (14)
Maine (32)
Maryland (897)
Massachusetts (5404)
Michigan (231)
Minnesota (331)
Mississippi (2)
Missouri (61)
Montana (11)
Nebraska (9)
Nevada (86)
New Hampshire (38)
New Jersey (2366)
New Mexico (13)
New York (2088)
North Carolina (1012)
North Dakota (5)
Northern California (3577)
Ohio (224)
Oklahoma (15)
Oregon (19)
Pennsylvania (1591)
Puerto Rico (7)
Rhode Island (28)
South America (754)
South Carolina (33)
Southern California (3038)
Tennessee (153)
Texas (1172)
United States (27039)
Utah (243)
Vermont (1)
Virginia (166)
Washington D.C. (52)
Washington State (597)
West Virginia (2)
Wisconsin (66)
Wyoming (2)
385,395 Results for "latham and phillips ophthalmic".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
December 2, 2025
·
3 min read
Press Releases
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
January 12, 2026
·
3 min read
Press Releases
Sagent Announces Launch of Travoprost Ophthalmic Solution, USP
September 16, 2025
·
2 min read
Press Releases
Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer
October 20, 2025
·
3 min read
Press Releases
Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
December 3, 2025
·
3 min read
Press Releases
Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
October 29, 2025
·
2 min read
Press Releases
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
September 24, 2025
·
3 min read
Press Releases
UPSHER-SMITH ADDS DIFLUPREDNATE OPHTHALMIC EMULSION TO ITS GENERICS PORTFOLIO
September 18, 2025
·
2 min read
Press Releases
Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.
January 15, 2026
·
3 min read
Business
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
I-Mab today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer.
June 6, 2024
·
5 min read
Previous
2 of 38,540
Next
